Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Avalo Therapeutics, Inc. | 40,323 | reported | 21 May 2026 | tx 32+1,355,721−195,293 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Avalo Therapeutics, Inc. | 39,900 | 0.00 USD | |
| 07 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 18,606 | 9.88 USD | 10b5-1 |
| 07 May 2026 | SALE | Avalo Therapeutics, Inc. | 18,606 | 24.12 USD | 10b5-1 |
| 07 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 18,606 | 0.00 USD | 10b5-1deriv |
| 06 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 47,000 | 8.04 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 13,834 | 18.55 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 12,347 | 19.28 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 2,700 | 20.76 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 9,219 | 21.37 USD | 10b5-1 |
| 06 May 2026 | SALE | Avalo Therapeutics, Inc. | 8,900 | 22.57 USD | 10b5-1 |
| 06 May 2026 | EXERCISE | Avalo Therapeutics, Inc. | 47,000 | 0.00 USD | 10b5-1deriv |
| 28 Mar 2026 | TAX_WITHHOLDING | Avalo Therapeutics, Inc. | 8,241 | 13.89 USD | |
| 28 Mar 2026 | EXERCISE | Avalo Therapeutics, Inc. | 24,200 | — | |
| 28 Mar 2026 | EXERCISE | Avalo Therapeutics, Inc. | 24,200 | 0.00 USD | deriv |
| 26 Feb 2026 | GRANT_AWARD | Avalo Therapeutics, Inc. | 105,000 | 0.00 USD | deriv |
| 10 Dec 2025 | TAX_WITHHOLDING | Avalo Therapeutics, Inc. | 155 | 4.10 USD | |
| 28 Mar 2025 | TAX_WITHHOLDING | Avalo Therapeutics, Inc. | 7,285 | 8.46 USD | |
| 28 Mar 2025 | EXERCISE | Avalo Therapeutics, Inc. | 24,200 | — | |
| 28 Mar 2025 | EXERCISE | Avalo Therapeutics, Inc. | 24,200 | 0.00 USD | deriv |
| 28 Jan 2025 | GRANT_AWARD | Avalo Therapeutics, Inc. | 163,000 | 0.00 USD | deriv |
| 13 Aug 2024 | GRANT_AWARD | Avalo Therapeutics, Inc. | 186,700 | 0.00 USD | deriv |
| 13 Aug 2024 | GRANT_AWARD | Avalo Therapeutics, Inc. | 72,600 | 0.00 USD | deriv |
| 09 Jun 2023 | PURCHASE | Avalo Therapeutics, Inc. | 511 | 3.42 USD | first after silence |
| 15 May 2023 | GRANT_AWARD | Avalo Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 13 Feb 2023 | GRANT_AWARD | Avalo Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 09 Jun 2023.